Breaking News

Fallout from the Dobbs decision on how, and maybe where, clinical trials are conducted; the FDA needs to ban an ineffective preterm labor drug; more 

    

 

First Opinion

Authors ushered out September with essays on ways the Dobbs decision might affect how, and even where. clinical trials are conducted; why the FDA needs to follow through with its plan to ban an ineffective drug for preterm labor; and more. And please check out the latest episode of the First Opinion Podcast.

STAT+: Subject, not suspect: The new hazards of conducting clinical research in the Dobbs era

By Aoife Brennan

Molly Ferguson for STAT

Criminalizing women for their reproductive health choices raises serious issues for clinical research in states that restrict abortion.

Read More

STAT+: FDA: Ignore a pharma company's deceptive racial equity argument for keeping Makena, an ineffective preterm labor drug

By Adam C. Urato

Adobe

A pharma company is arguing that Makena should be kept on the market because it may work in Black people. But it doesn't work in any people.

Read More

How the Inflation Reduction Act can help decarbonize the health care industry

By David Introcaso

Adobe

The Inflation Reduction Act's tax credits for renewable energy can help the healthy care industry reduce greenhouse gas emissions.

Read More

Listen: How the Dobbs decision could affect how and where clinical trials are conducted

By Patrick Skerrett

The Supreme Court's decision to overturn Roe v. Wade will have many trickle-down effects. Some will change how clinical trials are conducted.

Read More

Maternal-fetal surgery is not an alternative to abortion care

By Abigail Wilpers and Kristen Gosnell

Adobe

Some anti-abortion legislators say that maternal-fetal surgery renders abortion care unnecessary. They are wrong.

Read More

Rabies will continue to take lives without stronger human-animal health policies

By Terence Scott

CDC

Rabies kills almost 60,000 people every year. A One Health approach that focuses on vaccinating dogs could bring that to zero by 2030.

Read More

How health systems can truly value Black lives: help close the racial wealth gap

By George Dalembert and Atheendar Venkataramani and Eugenia C. South

Adobe

To truly value Black lives, health systems must be willing to tackle an upstream driver of racial health disparities: the racial wealth gap.

Read More

Doctors who knowingly spread Covid-19 lies should be held accountable

By Juliana E. Morris

Adobe

Legislation is sorely needed across the country to discipline for doctors who knowingly spread Covid-19 misinformation.

Read More

Medicare needs to cover the full spectrum of care for substance use disorders

By Fred Riccardi and Judith Stein and Ellen Weber

Julia Nikhinson/AP

Medicare covers only the least and most intensive levels of treatment for substance use disorders. It needs to cover the full spectrum.

Read More

The Inflation Reduction Act will help the U.S. achieve maximum vaccine access and uptake, but access gaps remain

By Richard Hughes IV

Adobe

The Inflation Reduction Act helps close the gaps in needed vaccinations, but more must be done to extend vaccine access to every American.

Read More

Sunday, October 2, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments